How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Household Sphygmomanometer Market
- By Product Type: Manual (Aneroid) Sphygmomanometers, Digital (Electronic) Sphygmomanometers, Hybrid Sphygmomanometers
- By Measurement Technique: Oscillometric, Auscultatory
- By Cuff Type: Standard Adult Cuff, Large Adult Cuff, Pediatric Cuff, Extra-Large Cuff
- By Power Source: Battery-Powered, Rechargeable Battery, Solar-Powered, Manual (No Power Source)
- By End User: Home Users, Healthcare Professionals, Elderly Users
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Manual (Aneroid) Sphygmomanometers leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Household Sphygmomanometer Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 3
Measurement Technique 2
Cuff Type 4
Power Source 4
End User 3
Companies profiled
Omron Healthcare
A&D Medical
Microlife Corporation
Welch Allyn (Hillrom)
Beurer GmbH
Rossmax International Ltd.
ANDON Health Co. Ltd.
NISSEI ASUKA MEDICAL CO.
LTD.
Citizen Systems Japan Co. Ltd.
iHealth Labs Inc.
Braun (Procter & Gamble)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Omron Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →A&D Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Microlife Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Welch Allyn (Hillrom)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Beurer GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Rossmax International Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ANDON Health Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →NISSEI ASUKA MEDICAL CO.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →LTD.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Citizen Systems Japan Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →iHealth Labs Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Braun (Procter & Gamble)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Philips Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Withings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Panasonic Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →AND Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,763M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Manual (Aneroid) Sphygmomanometers60.7
- Digital (Electronic) Sphygmomanometers14.0
- Hybrid Sphygmomanometers25.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$568.4M → $1,331M · 11.2%
Europe$396.2M → $927.2M · 11.2%
Asia Pacific$361.7M → $795.7M · 10.4%
Latin America$223.9M → $476.5M · 9.9%
Middle East and Africa$172.2M → $405.6M · 11.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.212026
10.232027
10.252028
10.252029
10.262030
10.282031
10.282032
10.302033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Omron Healthcare9.5
- A&D Medical20.6
- Microlife Corporation6.3
- Welch Allyn (Hillrom)10.6
- Beurer GmbH13.4
- Rossmax International Ltd.11.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type29.5%
Measurement Technique9.8%
Cuff Type21.8%
Power Source27.6%
End User11.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe23.6
- Asia Pacific20.2
- Latin America12.1
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Omron Healthcare | 96 | 75 | 83 | 77 | 95 | 95 | 87 |
| A&D Medical | 91 | 73 | 88 | 93 | 71 | 88 | 84 |
| Microlife Corporation | 65 | 87 | 66 | 70 | 67 | 77 | 72 |
| Welch Allyn (Hillrom) | 60 | 81 | 63 | 66 | 71 | 79 | 70 |
| Beurer GmbH | 70 | 64 | 69 | 57 | 60 | 59 | 63 |
| Rossmax International Ltd. | 60 | 64 | 67 | 61 | 58 | 62 | 62 |
| ANDON Health Co. Ltd. | 53 | 57 | 52 | 43 | 50 | 59 | 52 |
| NISSEI ASUKA MEDICAL CO. | 37 | 55 | 58 | 36 | 35 | 49 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Omron Healthcare
- A&D Medical
- Microlife Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Omron Healthcare | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| A&D Medical | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Microlife Corporation | ◐ | ◐ | − | − | − | ✓ |
| Welch Allyn (Hillrom) | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Beurer GmbH | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Rossmax International Ltd. | ◐ | − | − | ◐ | ◐ | ◐ |
| ANDON Health Co. Ltd. | − | ◐ | − | − | − | ◐ |
| NISSEI ASUKA MEDICAL CO. | ◐ | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Omron Healthcare87
2A&D Medical84
3Microlife Corporation72
4Welch Allyn (Hillrom)70
5Beurer GmbH63
6Rossmax International Ltd.62
7ANDON Health Co. Ltd.52
8NISSEI ASUKA MEDICAL CO.45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Omron HealthcareA&D Medical
Challenger2
Strong scale, closing on the leaders.
Microlife CorporationWelch Allyn (Hillrom)
Contender2
Focused players with pockets of strength.
Beurer GmbHRossmax International Ltd.
Niche2
Specialists in a single segment or region.
ANDON Health Co. Ltd.NISSEI ASUKA MEDICAL CO.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Household Sphygmomanometer Market — a $275M beachhead inside a $5.25B market.
Beachhead (SOM)$275Mobtainable near-term
Serviceable (SAM)$1.97Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Manual (Aneroid) Sphygmomanometers
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Digital (Electronic) Sphygmomanometers
Strong fit — clear ROI and a fast path to value.
End user68 fit
Hybrid Sphygmomanometers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Measurement Technique & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Cuff Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Household Sphygmomanometer Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation12%
Closed-won6%
$10.0KCAC
$43KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Household Sphygmomanometer Market is a resilient opportunity — $6.11B by 2033, compounding at 5.5%.
TAM · 2025$3.98Btoday
TAM · 2033$6.11Bforecast
CAGR5.5%2027–2033
Cumulative$44.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.11BTotal addressable market
SAM$2.17BServiceable available market
SOM$358MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.11BLarge & growingTAM by 2033 at 5.5% CAGR
$2.17BServiceable nowreachable with today’s model
$358MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.76BBear3.6% CAGR
$6.11BBase5.5% CAGR
$7.82BBull7.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Measurement Technique optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Household Sphygmomanometer Market — a $4.44B market by 2033. Plan: grow share from 7.2% to 11.2%.
Market size · 2033$4.44Btotal addressable
Market CAGR5.4%2027–2033
Target share11.2%from 7.2% today
Revenue ambition$497Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.2% | 11.2% | Ahead |
| Revenue | $344M | $497M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.8% | 44.6% | On track |
| Customer retention | 88.3% | 95.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Measurement Technique capability
A defensible second engine — invest in Measurement Technique to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Measurement Technique
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $67M capacity & capability investment
- Greenlight bolt-on M&A in Measurement Technique
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Household Sphygmomanometer Market conversation — a $7.11B market you can size, segment and defend in minutes.
Market size · 2033$7.11Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,560+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 2 mopayback period
$86K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Omron HealthcareA&D MedicalMicrolife CorporationWelch Allyn (Hillrom)Beurer GmbHRossmax International Ltd.ANDON Health Co. Ltd.NISSEI ASUKA MEDICAL CO.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Household Sphygmomanometer Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Household Sphygmomanometer Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Household Therapeutic Apparatus Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportHousehold Timer Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportHousehold Toaster Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportHousehold Vacuum Cleaning Robot Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportHousehold Washing and Drying Machines Market
Market size, share, segmentation and regional forecast.
$962M market · 2025 base year
View reportHousehold Waste Composters Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportHousehold Water Dispenser Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportHousehold Water Purifiers Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportHousehold Water Softener Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportHousehold Wind Turbine Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportHouseware Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportHousewares Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.